Skip to content

Clinical trials

Phase 2 Pulmonary Arterial Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Phase 2 Country / region: United States Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20065
20081
20095
20107
20115
20125
20133
20144
20152
20164
20173
20187
20197
20201
20213
20223
20235
20243
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated25
Recruiting10
Active, not recruiting2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion5
Novartis Pharmaceuticals5
Bastiaan Driehuys4
Lung Biotechnology PBC4
United Therapeutics4
University of Pennsylvania4
Gilead Sciences3
GlaxoSmithKline3
Merck Sharp & Dohme LLC3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension82
Hypertension, Pulmonary30
Familial Primary Pulmonary Hypertension6
Lung Diseases, Interstitial5
Idiopathic Pulmonary Fibrosis4
Connective Tissue Diseases3
Hypertension3
Lung Diseases3
Cardiovascular Diseases2
Cough2

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.